Postural orthostatic tachycardia syndrome after mRNA COVID-19 vaccine

Clin Auton Res. 2022 Aug;32(4):307-311. doi: 10.1007/s10286-022-00880-3. Epub 2022 Jul 23.

Authors

Ahmed M Eldokla^{1

2}, Mohammed T Numan³

Affiliations

¹ Department of Neurology, State University of New York, Upstate Medical University, Syracuse, NY, 13210, USA. EldoklaA@Upstate.edu.
² Department of Pathology, State University of New York, Upstate Medical University, Syracuse, NY, 13210, USA. EldoklaA@Upstate.edu.
³ Pediatric Cardiology, Children's Heart Institute, McGovern Medical School, UT Health Science Center, Houston, TX, 77030, USA.

No abstract available

Publication types

Letter

MeSH terms

COVID-19 Vaccines* / adverse effects
COVID-19*
Humans
Postural Orthostatic Tachycardia Syndrome* / diagnosis
Postural Orthostatic Tachycardia Syndrome* / etiology
RNA, Messenger

Substances

COVID-19 Vaccines
RNA, Messenger